Perception: Where functional MRI stops, metabolism starts
Combining techniques that track blood oxygenation and biochemicals during neuronal activity reveals how the brain computes perceived and unperceived stimuli.
- Wellcome Centre for Integrative Neuroimaging, University of Oxford, United Kingdom
Look around you, the room you are in, the people and objects that surround you. As you do, the visual cortex at the back of your brain becomes active and starts to process these perceived stimuli in multiple stages of increased complexity: lines and colours are computed by the primary visual regions which then forward this information to secondary areas that piece together these simple features into people and objects.
Visual information is usually presented at a rate that your visual cortex can process, but this is not always the case. The very monitor you are reading this article on, for example, probably updates its display at least 60 times a second. Such a fast rate cannot be perceived, which is why we only register a steady image or a smooth video rather than continuous flickering. Unperceived stimulation is not fully processed by the visual stream, but it may still elicit activity in the primary visual cortex. In fact, little is known about how the brain handles unperceived signals; this is partly because current approaches in brain imaging cannot distinguish between perceived and unperceived signals in the visual cortex.
Now, in eLife, Federico Giove and colleagues based in Italy, Germany and the United States – including Mauro DiNuzzo and Silvia Mangia as joint first authors – report having leveraged two magnetic resonance imaging techniques to explore how to best track the way energy is supplied to the visual cortex for perception (DiNuzzo et al., 2022).
Brain areas that process information need glucose and oxygen to replenish the energy they consume, with these substances being provided by blood vessels coupled to active neurons. Tracking this neurovascular response using functional magnetic resonance imaging (fMRI) and blood-oxygen-level dependent (BOLD) imaging allows scientists to detect active brain regions non-invasively. However, these approaches can only produce a surrogate signal that reflects the brain’s change in oxygen demands; they do not describe neuronal activity per se. In fact, measured changes in BOLD-fMRI are non-specific: they may reflect energy consumption in excitatory neurons, in inhibitory interneurons, or even in a combination of the two (Logothetis, 2008; Moon et al., 2021). For instance, visual tasks with similar neurovascular responses can actually encompass different local inhibitory processes (Frangou et al., 2018). BOLD-fMRI alone may therefore not be sufficient to describe complex cognitive processes at the neuronal level, and to reveal how the same brain regions compute perceived and unperceived stimuli differently.
Examining the biochemical clues left by neural activity could help to overcome this limitation. The levels of lactate and glutamate – two molecules involved in neural processes – can be used to directly assess how metabolic systems change in active areas of the brain. This can be measured using functional magnetic resonance spectroscopy (fMRS), a technique which quantifies chemical compounds within a three-dimensional volume. As recent studies show, combining BOLD-fMRI with fMRS that records glutamate and lactate concentrations can help to dissect the neural processes at play in active brain areas (Mangia et al., 2007; Schaller et al., 2014; Ip et al., 2017; Boillat et al., 2020; Koush et al., 2021).
DiNuzzo et al. capitalized on these methodological advances and harnessed BOLD-fMRI combined with fMRS to examine the brains of participants watching green/red checkerboards that switched their colours either slowly (7.5 Hertz; perceived stimuli) or quickly (30 Hertz; unperceived stimuli). Both perceived and unperceived stimuli were carefully designed to elicit similar neurovascular responses in the primary visual cortex. And, indeed, the BOLD-fMRI signal in the primary visual cortex was the same between perceived and unperceived stimuli (Figure 1a), both within the anatomically defined primary visual cortex and in the three-dimensional volume used in fMRS. Finer measures of the neurovascular response, such as when it started or when it peaked, also did not differ between perceived and unperceived stimulations. Measuring BOLD-fMRI signal in secondary visual areas corroborated the notion that unperceived stimuli are not processed further in the visual stream (Figure 1c). This suggests that the neurovascular response in the primary visual cortex cannot, by itself, distinguish between different local processing of perceived and unperceived stimuli.
Figure 1
Perception drives the brain’s neurometabolic but not neurovascular response to visual stimulation.
Participants were presented with checkerboards that flickered between different colours. In the perceived condition, the red and green checkerboards switched colours slowly (7.5 Hertz); in the unperceived condition, they switched quickly (30 Hertz) and appeared as static yellow. (a) The neurovascular response (as measured by BOLD-fMRI) was not different between the two conditions (green bar, perceived; yellow bar, unperceived) in the primary visual cortex, defined as an anatomical brain region (dark grey) or as the three-dimensional volume used in fMRS (red). (b) Compared to rest, perceived stimulation upregulated the neurometabolic response in the primary visual cortex, as indicated by increased concentration of lactate and glutamate in this area. This response did not take place during the unperceived condition. (c) The neurovascular response was enhanced in the secondary visual cortex (highlighted in darker shades of grey) only for the perceived condition.
Image credit: Brain images in Figure 1a, 1b and 1c are adapted from illustrations by the Database Center for Life Science (CC-BY-SA-2.1-jp); the panel in Figure 1b is adapted from DiNuzzo et al., 2022 (Figure 3—figure supplement 5; CC BY 4.0)
DiNuzzo et al. then used fMRS to measure the changes in glutamate and lactate concentration during perceived and unperceived stimulation compared to rest. They found increased lactate and glutamate in the primary visual cortex for perceived – but not unperceived – stimulation (Figure 1b). Perception may therefore upregulate energy metabolism so that information can be forwarded from the primary to the secondary visual cortex.
In conclusion, combining BOLD-fMRI and fMRS allowed DiNuzzo et al. to show that similar neurovascular responses (as measured by BOLD-fMRI) may reflect different neurometabolic responses (as measured by fMRS) depending on whether a stimulus is perceived. In fact, the results suggest that, compared to neurovascular responses, changes in neurometabolic responses may be a more appropriate indicator of visual perceptual processes and output activity from primary to secondary visual regions. Over the past 20 years, BOLD-fMRI has been one of the most common brain imaging methods for investigating human cognition non-invasively; the study by DiNuzzo et al. now further supports the need to combine approaches in brain imaging to better decipher precise neuronal processes.
References
-
Metabolite concentration changes associated with positive and negative BOLD responses in the human visual cortex: A functional MRS study at 7 TeslaJournal of Cerebral Blood Flow and Metabolism 40:488–500.https://doi.org/10.1177/0271678X19831022
-
Metabolic underpinnings of activated and deactivated cortical areas in human brainJournal of Cerebral Blood Flow and Metabolism 41:986–1000.https://doi.org/10.1177/0271678X21989186
-
Sustained neuronal activation raises oxidative metabolism to a new steady-state level: evidence from 1H NMR spectroscopy in the human visual cortexJournal of Cerebral Blood Flow and Metabolism 27:1055–1063.https://doi.org/10.1038/sj.jcbfm.9600401
-
Contribution of excitatory and inhibitory neuronal activity to BOLD fMRICerebral Cortex 31:4053–4067.https://doi.org/10.1093/cercor/bhab068
Article and author information
Author details
Acknowledgements
Polytimi Frangou is funded by a Sir Henry Wellcome Postdoctoral Fellowship (224109/Z/21/Z). William T Clarke is funded by the Wellcome Trust and the Royal Society (102584/Z/13/Z). The Wellcome Centre for Integrative Neuroimaging is supported by core funding from the Wellcome Trust (203139/Z/16/Z).
Publication history
Copyright
© 2022, Frangou and Clarke
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,298
- views
-
- 133
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Perception: Where functional MRI stops, metabolism starts
eLife 11:e78327.
https://doi.org/10.7554/eLife.78327
Further reading
-
- Neuroscience
Alzheimer’s disease (AD) leads to progressive memory decline, and alterations in hippocampal function are among the earliest pathological features observed in human and animal studies. GABAergic interneurons (INs) within the hippocampus coordinate network activity, among which type 3 interneuron-specific (I-S3) cells expressing vasoactive intestinal polypeptide and calretinin play a crucial role. These cells provide primarily disinhibition to principal excitatory cells (PCs) in the hippocampal CA1 region, regulating incoming inputs and memory formation. However, it remains unclear whether AD pathology induces changes in the activity of I-S3 cells, impacting the hippocampal network motifs. Here, using young adult 3xTg-AD mice, we found that while the density and morphology of I-S3 cells remain unaffected, there were significant changes in their firing output. Specifically, I-S3 cells displayed elongated action potentials and decreased firing rates, which was associated with a reduced inhibition of CA1 INs and their higher recruitment during spatial decision-making and object exploration tasks. Furthermore, the activation of CA1 PCs was also impacted, signifying early disruptions in CA1 network functionality. These findings suggest that altered firing patterns of I-S3 cells might initiate early-stage dysfunction in hippocampal CA1 circuits, potentially influencing the progression of AD pathology.
-
- Cell Biology
- Neuroscience
Reactive astrocytes play critical roles in the occurrence of various neurological diseases such as multiple sclerosis. Activation of astrocytes is often accompanied by a glycolysis-dominant metabolic switch. However, the role and molecular mechanism of metabolic reprogramming in activation of astrocytes have not been clarified. Here, we found that PKM2, a rate-limiting enzyme of glycolysis, displayed nuclear translocation in astrocytes of EAE (experimental autoimmune encephalomyelitis) mice, an animal model of multiple sclerosis. Prevention of PKM2 nuclear import by DASA-58 significantly reduced the activation of mice primary astrocytes, which was observed by decreased proliferation, glycolysis and secretion of inflammatory cytokines. Most importantly, we identified the ubiquitination-mediated regulation of PKM2 nuclear import by ubiquitin ligase TRIM21. TRIM21 interacted with PKM2, promoted its nuclear translocation and stimulated its nuclear activity to phosphorylate STAT3, NF-κB and interact with c-myc. Further single-cell RNA sequencing and immunofluorescence staining demonstrated that TRIM21 expression was upregulated in astrocytes of EAE. TRIM21 overexpressing in mice primary astrocytes enhanced PKM2-dependent glycolysis and proliferation, which could be reversed by DASA-58. Moreover, intracerebroventricular injection of a lentiviral vector to knockdown TRIM21 in astrocytes or intraperitoneal injection of TEPP-46, which inhibit the nuclear translocation of PKM2, effectively decreased disease severity, CNS inflammation and demyelination in EAE. Collectively, our study provides novel insights into the pathological function of nuclear glycolytic enzyme PKM2 and ubiquitination-mediated regulatory mechanism that are involved in astrocyte activation. Targeting this axis may be a potential therapeutic strategy for the treatment of astrocyte-involved neurological disease.
